Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099441968> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2099441968 endingPage "74" @default.
- W2099441968 startingPage "5469" @default.
- W2099441968 abstract "Because efficient i.v. administration of interleukin 2 (IL-2) in tumor patients leads to severe cardiopulmonary side effects, we developed a new form of IL-2 application that allows activation of all IL-2-responsive immune cells directly at the tumor site. In five patients with T4N0M0 transitional cell carcinoma of the bladder, we used high-dose, continuous IL-2 perfusion of the bladder (1000 units/ml, 2 ml/min, 24 h/day), for 5 days after incomplete transurethral resection of the tumor. The total dose, 15 million units, was repeated after 4-12 weeks. None of our patients showed any evidence of side effects. In blood and especially in urine, the number of eosinophil leukocytes was remarkably increased. Eosinophils were attached to the tumor cells and degranulated on them. Before treatment, no cells positive for IL-2 receptors were found in urine, and only 0-3% of lymphocytes positive for IL-2 receptors were detected in blood. After the first cycle and especially after the second, a distinct increase in positive cells up to 17% occurred. One patient had a complete histologically confirmed remission and is free of tumor 6 months after therapy. Another patient died of a vertebral metastasis 8 weeks after the first (and only) therapeutic cycle. Local administration of a high dose of IL-2 induces local and systemic immunopotentiation diagnosed by activation marker analysis without any side effects and can be used in inoperable transitional cell carcinoma of the bladder. The optimal dosage still needs to be defined. Bladder carcinoma is an ideal model that offers a unique chance to use urine cytology to study the cooperation and activation of immune cells at the tumor site." @default.
- W2099441968 created "2016-06-24" @default.
- W2099441968 creator A5012637812 @default.
- W2099441968 creator A5089661293 @default.
- W2099441968 date "1989-10-01" @default.
- W2099441968 modified "2023-09-23" @default.
- W2099441968 title "Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma." @default.
- W2099441968 cites W1490918588 @default.
- W2099441968 cites W1545874654 @default.
- W2099441968 cites W1589105822 @default.
- W2099441968 cites W1971672446 @default.
- W2099441968 cites W1996124465 @default.
- W2099441968 cites W2008142392 @default.
- W2099441968 cites W2026935319 @default.
- W2099441968 cites W2049822454 @default.
- W2099441968 cites W2053265457 @default.
- W2099441968 cites W2058331779 @default.
- W2099441968 cites W2078366321 @default.
- W2099441968 cites W2092355198 @default.
- W2099441968 cites W2124013207 @default.
- W2099441968 cites W2125816210 @default.
- W2099441968 cites W2143265310 @default.
- W2099441968 cites W2322553446 @default.
- W2099441968 cites W2326245275 @default.
- W2099441968 cites W2432291220 @default.
- W2099441968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2788500" @default.
- W2099441968 hasPublicationYear "1989" @default.
- W2099441968 type Work @default.
- W2099441968 sameAs 2099441968 @default.
- W2099441968 citedByCount "34" @default.
- W2099441968 countsByYear W20994419682012 @default.
- W2099441968 countsByYear W20994419682013 @default.
- W2099441968 countsByYear W20994419682018 @default.
- W2099441968 countsByYear W20994419682020 @default.
- W2099441968 countsByYear W20994419682022 @default.
- W2099441968 crossrefType "journal-article" @default.
- W2099441968 hasAuthorship W2099441968A5012637812 @default.
- W2099441968 hasAuthorship W2099441968A5089661293 @default.
- W2099441968 hasConcept C121608353 @default.
- W2099441968 hasConcept C126322002 @default.
- W2099441968 hasConcept C126894567 @default.
- W2099441968 hasConcept C170493617 @default.
- W2099441968 hasConcept C2776042228 @default.
- W2099441968 hasConcept C2777037409 @default.
- W2099441968 hasConcept C2777371288 @default.
- W2099441968 hasConcept C2777546739 @default.
- W2099441968 hasConcept C2778065480 @default.
- W2099441968 hasConcept C2779013556 @default.
- W2099441968 hasConcept C2779762690 @default.
- W2099441968 hasConcept C2780352672 @default.
- W2099441968 hasConcept C71924100 @default.
- W2099441968 hasConcept C90924648 @default.
- W2099441968 hasConceptScore W2099441968C121608353 @default.
- W2099441968 hasConceptScore W2099441968C126322002 @default.
- W2099441968 hasConceptScore W2099441968C126894567 @default.
- W2099441968 hasConceptScore W2099441968C170493617 @default.
- W2099441968 hasConceptScore W2099441968C2776042228 @default.
- W2099441968 hasConceptScore W2099441968C2777037409 @default.
- W2099441968 hasConceptScore W2099441968C2777371288 @default.
- W2099441968 hasConceptScore W2099441968C2777546739 @default.
- W2099441968 hasConceptScore W2099441968C2778065480 @default.
- W2099441968 hasConceptScore W2099441968C2779013556 @default.
- W2099441968 hasConceptScore W2099441968C2779762690 @default.
- W2099441968 hasConceptScore W2099441968C2780352672 @default.
- W2099441968 hasConceptScore W2099441968C71924100 @default.
- W2099441968 hasConceptScore W2099441968C90924648 @default.
- W2099441968 hasIssue "19" @default.
- W2099441968 hasLocation W20994419681 @default.
- W2099441968 hasOpenAccess W2099441968 @default.
- W2099441968 hasPrimaryLocation W20994419681 @default.
- W2099441968 hasRelatedWork W1492299964 @default.
- W2099441968 hasRelatedWork W2016391185 @default.
- W2099441968 hasRelatedWork W2062819090 @default.
- W2099441968 hasRelatedWork W2368159503 @default.
- W2099441968 hasRelatedWork W2368502972 @default.
- W2099441968 hasRelatedWork W2369087181 @default.
- W2099441968 hasRelatedWork W2377652014 @default.
- W2099441968 hasRelatedWork W2393309228 @default.
- W2099441968 hasRelatedWork W2418031634 @default.
- W2099441968 hasRelatedWork W2463117135 @default.
- W2099441968 hasVolume "49" @default.
- W2099441968 isParatext "false" @default.
- W2099441968 isRetracted "false" @default.
- W2099441968 magId "2099441968" @default.
- W2099441968 workType "article" @default.